Tavaborole Solution
Product Images NDC 51862-690

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tavaborole (NDC 51862-690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mayne Pharma Commercial Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tavaborole 01)

FDA Label Image

Figure A And Figure B (Tavaborole 02)

FDA Label Image

Figure C (Tavaborole 03)

FDA Label Image

Figure D (Tavaborole 04)

FDA Label Image

Figure E And Figure F (Tavaborole 05)

FDA Label Image

Principal Display Panel (10 mL Bottle Label)

Principal Display Panel (10 mL Bottle Label)
NDC 51862-690-10 is a topical solution with 5% Tavaborole for external use only. It must not be used orally, vaginally or ophthalmically. The product must be stored between 20-25°C (68-77°F), with short-term excursions between 15-30°C (59-86°F) allowed. This 10mL product package has natural rubber in its packaging. It is only available with a prescription and is distributed by Mayne Pharma in Greenville, NC 27834. Code: GO/DRUGS/361.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.